Cargando…
Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
Aspirin therapy has shown protective effects against hepatocellular carcinoma (HCC) in preclinical studies. However, it is unclear whether aspirin therapy lowers the risk of HCC in patients with alcoholic cirrhosis. A retrospective analysis of data from 949 consecutive patients with alcoholic cirrho...
Autores principales: | Shin, Sangdeok, Lee, Sang Hoon, Lee, Minjong, Kim, Ji Hyun, Lee, Wongu, Lee, Hyun Woo, Park, Min Soo, Park, Seungwoo, Kim, Tae Suk, Choi, Dae Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478404/ https://www.ncbi.nlm.nih.gov/pubmed/32118712 http://dx.doi.org/10.1097/MD.0000000000019008 |
Ejemplares similares
-
CLIF–SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis
por: Jeong, Jin Hee, et al.
Publicado: (2016) -
Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis
por: Kim, Ji Hyun, et al.
Publicado: (2018) -
Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma
por: Kim, Cha Young, et al.
Publicado: (2017) -
Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience
por: Shin, Jongbeom, et al.
Publicado: (2019) -
Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
por: Kim, Ji Hyun, et al.
Publicado: (2020)